There have been dramatic developments this week for a class of weight loss drugs known as CB1 antagonists, which Peter brought up earlier this week. Dr Arya Sharma has an excellent post on his blog describing the risks and benefits of this class of medications, and what we can expect now that they are no longer available. A great read for anyone who is interested in the medical treatment of obesity.
Enjoyed this story? Share it with your friends by clicking the buttons below!
To get future posts delivered directly to your email inbox or to your RSS reader, be sure to subscribe to Obesity Panacea.
Enjoyed this story? Share it with your friends by clicking the buttons below!
To get future posts delivered directly to your email inbox or to your RSS reader, be sure to subscribe to Obesity Panacea.
|
0 Response to "A CB1 update"